IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Others diseases being investigated for the use of IFN-expressing adenoviral vectors include hepatocellular cancer, breast cancer, small cell lung cancer, and chronic myelogenous leukemia [52,53,54].